Menu

RVL Pharmaceuticals plc RVLPQ

Full chart Compare
Set alert

Price alert · RVLPQ

All alert types
0.00 USD 0.00 (+0.00%)

At closeOct 27, 2026, 4:00 PM EDT

0.000001 Day range 0.0005
0.000001 52-week range 0.0005
YTD
0.00%
1 year
0.00%

Revenue & Expenses

Income Tax Benefit → Expenses: $20.00KExpenses → Selling, General & Admin: $81.98MExpenses → Research & Development: $3.97MExpenses → Interest Expense: $3.11MExpenses → Other Expenses: $2.92MGross Profit → Expenses: $40.27MRevenue → Gross Profit: $40.27MRevenue → Cost of Revenue: $9.46MNet Loss → Expenses: $51.69MIncome Tax Benefit$20.00KGross Profit$40.27MNet Loss$51.69MCost of Revenue$9.46MExpenses$91.98MSelling, General & Admin$81.98MResearch & Development$3.97MInterest Expense$3.11MOther Expenses$2.92MRevenue$49.72M

Latest period ending Dec 31, 2022 · select a line to chart its full history

RVLPQ annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
49.72M17.50M27.76M240.03M263.70M
40.27M13.88M24.47M128.40M123.62M
-58.99M-82.75M-90.65M-280.69M-98.54M
-51.69M-64.92M-79.59M-270.90M-109.68M
-0.58-0.96-1.31-5.17-2.42
RVLPQ annual balance sheet
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
44.54M40.44M114.05M95.86M70.83M
128.51M144.67M370.95M463.25M795.62M
77.42M67.94M277.09M348.55M411.78M
57.49M47.65M221.62M273.30M268.83M
51.09M76.73M93.86M114.71M383.85M
RVLPQ annual cash flow
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
-37.81M-54.73M17.59M33.57M37.56M
126.00K116.45M-3.08M-4.02M-4.13M
41.78M-135.33M3.68M-4.69M3.60M
126.00K-1.69M-3.08M-4.02M-4.13M
4.10M-73.61M18.19M24.86M37.03M